CSL.AX · CSL LIMITED
Australia · RS rating 93 · As of 2026-10-14
| Price | 184.59 AUD |
|---|---|
| 1-day change | +0.0% |
| RS rating (overall / 1M / 3M / 12M) | 93 / 85 / 95 / 56 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 41 / 49 / 32 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +16.4% |
| Market cap (USD) | $61.4B |